MEMIX
Price
$45.19
Change
-$0.08 (-0.18%)
Updated
Nov 19 closing price
Net Assets
9.23B
VEIEX
Price
$34.03
Change
-$0.05 (-0.15%)
Updated
Nov 19 closing price
Net Assets
141.19B
Interact to see
Advertisement

MEMIX vs VEIEX

Header iconMEMIX vs VEIEX Comparison
Open Charts MEMIX vs VEIEXBanner chart's image
MFS Emerging Markets Equity I
Price$45.19
Change-$0.08 (-0.18%)
VolumeN/A
Net Assets9.23B
Vanguard Emerging Mkts Stock Idx I
Price$34.03
Change-$0.05 (-0.15%)
VolumeN/A
Net Assets141.19B
MEMIX vs VEIEX Comparison Chart in %
View a ticker or compare two or three
VS
MEMIX vs. VEIEX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEMIX is a Hold and VEIEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEIEX has more cash in the bank: 141B vs. MEMIX (9.23B). VEIEX pays higher dividends than MEMIX: VEIEX (2.61) vs MEMIX (1.88). MEMIX was incepted earlier than VEIEX: MEMIX (29 years) vs VEIEX (32 years). MEMIX (1.10) is less costly to investors than VEIEX (0.29). MEMIX is a more actively managed with annual turnover of: 36.00 vs. VEIEX (8.00). MEMIX (0) and VEIEX (0) have matching initial minimum investment requirements. MEMIX annual gain was more profitable for investors over the last year : 29.15 vs. VEIEX (20.18). MEMIX return over 5 years is better than : 26.73 vs. VEIEX (23.38).
MEMIXVEIEXMEMIX / VEIEX
Total Expense Ratio1.060.29366%
Annual Report Gross Expense Ratio1.100.29379%
Fund Existence29 years32 years-
Gain YTD30.04322.205135%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets9.23B141B7%
Annual Yield % from dividends1.882.6172%
Returns for 1 year29.1520.18144%
Returns for 3 years64.2047.23136%
Returns for 5 years26.7323.38114%
Returns for 10 years91.0678.61116%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CUE0.58N/A
+0.02%
Cue Biopharma
RNGR13.51N/A
N/A
Ranger Energy Services
MTSR70.50N/A
N/A
Metsera Inc
CHPGU10.26N/A
N/A
Championsgate Acquisition Corp
TRVI11.05-0.26
-2.30%
Trevi Therapeutics